Herpes simplex virus infection in sensory ganglia: immune control, latency, and reactivation
Openshaw, H.; Puga, A.; Notkins, A.L.
Federation Proceedings 38(13): 2660-2664
1979
ISSN/ISBN: 0014-9446 PMID: 228982 Document Number: 148146
Document emailed within 1 workday
Related Documents
Boulinguez, S.; Rogez, S. 1997: Herpes simplex virus: mechanism of latency and reactivation phases Annales de Dermatologie et de Venereologie 124(5): 409-415Rajcáni, J.; Sabó, A.; Mucha, V.; Kostál, M.; Compel, P. 1995: Herpes simplex virus type 1 envelope subunit vaccine not only protects against lethal virus challenge, but also may restrict latency and virus reactivation Acta Virologica 39(1): 37-49
Cremer, K.; Wohlenberg, C.; Notkins, A.L.; Mackett, M.; Moss, B. 1985: Vaccinia virus recombinant that expresses the herpes simplex virus type 1 glycoprotein d gene protects mice against lethal challenge by herpes simplex virus type 1 or herpes simplex type 2 and the establishment of a latent ganglionic infection by herpes simplex virus type 1 Lerner, R A , R M Chanock And F Brown (Ed ) Vaccines 85: Molecular And Chemical Basis Of Resistance to Parasitic, Bacterial, And Viral Diseases; Meeting, 1983 Xxi+407p Cold Spring Harbor Laboratory: Cold Spring Harbor, N Y , Usa Illus Paper 169-174
Cremer, K.; Wohlenberg, C.; Notkins, A.L.; Mackett, M.; Moss, B. 1985: Vaccinia virus recombinant that expresses the herpes simplex virus type 1 glycoprotein d gene protects mice against lethal challenge by herpes simplex virus type 1 or herpes simplex type 2 and the establishment of a latent ganglionic infection by herpes simplex virus type 1 Lerner, R A , R M Chanock And F Brown (Ed ) Vaccines 85: Molecular And Chemical Basis Of Resistance to Parasitic, Bacterial, And Viral Diseases; Meeting, 1983 Xxi+407p Cold Spring Harbor Laboratory: Cold Spring Harbor, N Y , Usa Illus Paper 169-174
Cunningham, A.L.; Mikloska, Z. 2001: The Holy Grail: immune control of human herpes simplex virus infection and disease Herpes: the Journal of the Ihmf 8(Suppl 1): 6a
Marttila, R. 1977: Latency of herpes simplex virus Duodecim; Laaketieteellinen Aikakauskirja 93(4): 253-255
Morahan, P.S.; Breinig, M.C.; McGeorge, M.B. 1978: Immune responses to vaginal or systemic infection of mice with herpes simplex virus type 2 Iarc Scientific Publications 1978(24 Part 2): 759-763
Wang, Z.-y.; Wang, Z.-y.; Wen, H.-L.; Tao, Z.-x. 2005: ELISA study on application of recombinant glycoprotein D of herpes simplex virus-1 in diagnosis of herpes simplex virus-1 infection with ELISA Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 19(2): 159-161
Aguilar, L.; Giménez, M.J.; Prieto, J. 2005: Is prevention of reactivation of herpes simplex 1 virus necessary in cosmetic surgery and dermatological procedures? Revista Espanola de Quimioterapia: Publicacion Oficial de la Sociedad Espanola de Quimioterapia 18(2): 118-123
Maeglin, B. 1987: Herpes simplex. Oral and peroral infection with Herpes simplex virus Schweizer Monatsschrift für Zahnmedizin 97(12): 1532-1536
Warren, K.G.; Devlin, M.; Gilden, D.H.; Wroblewska, Z.; Koprowski, H.; Brown, S.M.; Subak-Sharpe, J. 1978: Herpes simplex virus latency in patients with multiple sclerosis, lymphoma and normal humans Iarc Scientific Publications 1978(24 Part 2): 765-768
Kúdelová, M.; Kostál, M.; Cervenáková, L.; Rajcáni, J.; Kaerner, H.C. 1991: Pathogenicity and latency competence for rabbits of the herpes simplex virus type 1 ANGpath gC and gE defective mutants Acta Virologica 35(5): 438-449
Sheridan, J.F.; Beck, M.; Smith, C.C.; Aurelian, L. 1987: Reactivation of herpes simplex virus is associated with production of a low molecular weight factor that inhibits lymphokine activity in vitro Journal of Immunology 138(4): 1234-1239
Puthavathana, P.; Kanyok, R.; Horthongkham, N.; Roongpisuthipong, A. 1998: Prevalence of herpes simplex virus infection in patients suspected of genital herpes; and virus typing by type specific fluorescent monoclonal antibodies Journal of the Medical Association of Thailand 81(4): 260-264
Meylan, P. 2005: Recommandations suisses pour le traitement de l'herpès génital et de l'herpès du nouveau-né - Swiss recommendations for the management of genital herpes and herpes simplex virus infection of the neonate Revue Medicale Suisse 1(36): 2315-2326
Slomka, M.J. 1996: Seroepidemiology and control of genital herpes: the value of type specific antibodies to herpes simplex virus Communicable Disease Report. Cdr Review 6(3): R41-R45
Rajcáni, J.; Reefschläger, J. 1987: Efficacy of (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil against acute herpes simplex virus keratitis and the establishment of latency: comparison with acyclovir and bromovinyldeoxyuridine Acta Virologica 31(4): 329-339
Prober, C.G.; Sullender, W.M.; Yasukawa, L.L.; Au, D.S.; Yeager, A.S.; Arvin, A.M. 1987: Low risk of herpes simplex virus infections in neonates exposed to the virus at the time of vaginal delivery to mothers with recurrent genital herpes simplex virus infections New England Journal of Medicine 316(5): 240-244
Baker, D.A.; Gonik, B.; Milch, P.O.; Berkowitz, A.; Lipson, S.; Verma, U. 1989: Clinical evaluation of a new herpes simplex virus ELISA: a rapid diagnostic test for herpes simplex virus Obstetrics and Gynecology 73(3 Part 1): 322-325
Terleth, C.; van Laar, T.; Schouten, R.; van Steeg, H.; Hodemaekers, H.; Wormhoudt, T.; Cornelissen-Steijger, P.D.; Abrahams, P.J.; van der Eb, A.J. 1997: A lack of radiation-induced ornithine decarboxylase activity prevents enhanced reactivation of herpes simplex virus and is linked to non-cancer proneness in xeroderma pigmentosum patients Cancer Research 57(19): 4384-4392